Generative adversarial networks in medical image augmentation: a review

Y Chen, XH Yang, Z Wei, AA Heidari, N Zheng… - Computers in Biology …, 2022 - Elsevier
Object With the development of deep learning, the number of training samples for medical
image-based diagnosis and treatment models is increasing. Generative Adversarial …

The miRNA: a small but powerful RNA for COVID-19

S Zhang, K Amahong, X Sun, X Lian, J Liu… - Briefings in …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is a severe and rapidly evolving epidemic. Now …

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

Y Zhou, Y Zhang, X Lian, F Li, C Wang… - Nucleic acids …, 2022 - academic.oup.com
Drug discovery relies on the knowledge of not only drugs and targets, but also the
comparative agents and targets. These include poor binders and non-binders for developing …

Multilevel threshold image segmentation for COVID-19 chest radiography: A framework using horizontal and vertical multiverse optimization

H Su, D Zhao, H Elmannai, AA Heidari… - Computers in Biology …, 2022 - Elsevier
COVID-19 is currently raging worldwide, with more patients being diagnosed every day. It
usually is diagnosed by examining pathological photographs of the patient's lungs. There is …

Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics

Y Wang, S Zhang, F Li, Y Zhou, Y Zhang… - Nucleic acids …, 2020 - academic.oup.com
Abstract Knowledge of therapeutic targets and early drug candidates is useful for improved
drug discovery. In particular, information about target regulators and the patented …

POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability

F Li, Y Zhou, Y Zhang, J Yin, Y Qiu… - Briefings in …, 2022 - academic.oup.com
Mass spectrometry-based proteomic technique has become indispensable in current
exploration of complex and dynamic biological processes. Instrument development has …

DrugMAP: molecular atlas and pharma-information of all drugs

F Li, J Yin, M Lu, M Mou, Z Li, Z Zeng, Y Tan… - Nucleic acids …, 2023 - academic.oup.com
The efficacy and safety of drugs are widely known to be determined by their interactions with
multiple molecules of pharmacological importance, and it is therefore essential to …

NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data

Q Yang, Y Wang, Y Zhang, F Li, W Xia… - Nucleic Acids …, 2020 - academic.oup.com
Biological processes (like microbial growth & physiological response) are usually dynamic
and require the monitoring of metabolic variation at different time-points. Moreover, there is …

Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram

W Xue, T Fu, S Deng, F Yang, J Yang… - ACS chemical …, 2022 - ACS Publications
Human serotine transporter (hSERT) is one of the most influential drug targets, and its
allosteric modulators (eg, escitalopram) have emerged to be the next-generation medication …

VARIDT 2.0: structural variability of drug transporter

T Fu, F Li, Y Zhang, J Yin, W Qiu, X Li, X Liu… - Nucleic Acids …, 2022 - academic.oup.com
The structural variability data of drug transporter (DT) are key for research on precision
medicine and rational drug use. However, these valuable data are not sufficiently covered …